Akoya Biosciences Inc. announced that it received an unsolicited acquisition proposal from a third party, referred to as Party A, to acquire the company in an all-cash tender offer. The proposal offers Akoya shareholders $1.40 per share in cash. This development follows Akoya's earlier agreement to merge with Quanterix Corporation, under which Akoya would become a wholly owned subsidiary of Quanterix. Akoya's board, after consulting with financial and legal advisors, has determined that the unsolicited proposal could potentially lead to a superior offer and is therefore engaging in discussions with Party A to explore the proposal further.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.